Home > Clinical Trials

Saved trials

Completed
NCT01465828
Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE Trial
30 Enrollment(s)
2 Study location(s)
Interventional (Phase III)
Acute Coronary Syndrome
Unknown status
NCT01557075
Aspirin Mono Therapy 12-months After Drug-eluting Stents Implantation
2,000 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Drug-eluting Stent (DES)
Completed
NCT00846365
Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension
1,085 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Essential Hypertension
Terminated
NCT01107899
Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes
29 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Acute Coronary Syndromes
Completed
NCT01305369
The Effect of Prasugrel on Bronchial Hyperreactivity and on Markers of Inflammation in Patients With Chronic Asthma
26 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Chronic Asthma
Unknown status
NCT01046461
Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer
41 Enrollment(s)
1 Study location(s)
Interventional (Phase II)
Solid Tumour
Postoperative Nausea and Vomiting
Completed
NCT01178099
An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults
26 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Anemia, Sickle Cell
Completed
NCT01033071
Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.
1,071 Enrollment(s)
0 Study location(s)
Interventional (Phase III)
Essential Hypertension